"Disease-Free Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.
| Descriptor ID |
D018572
|
| MeSH Number(s) |
E01.789.200 E05.318.740.998.300 N05.715.360.750.795.300 N06.850.520.830.998.300
|
| Concept/Terms |
Disease-Free Survival- Disease-Free Survival
- Disease Free Survival
- Event-Free Survival
- Event Free Survival
- Event-Free Survivals
- Survival, Event-Free
- Survivals, Event-Free
- Survival, Disease-Free
- Disease-Free Survivals
- Survival, Disease Free
- Survivals, Disease-Free
Progression-Free Survival- Progression-Free Survival
- Progression Free Survival
- Progression-Free Survivals
- Survival, Progression-Free
- Survivals, Progression-Free
|
Below are MeSH descriptors whose meaning is more general than "Disease-Free Survival".
Below are MeSH descriptors whose meaning is more specific than "Disease-Free Survival".
This graph shows the total number of publications written about "Disease-Free Survival" by people in this website by year, and whether "Disease-Free Survival" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 8 | 8 |
| 1995 | 0 | 28 | 28 |
| 1996 | 0 | 27 | 27 |
| 1997 | 0 | 44 | 44 |
| 1998 | 0 | 68 | 68 |
| 1999 | 0 | 46 | 46 |
| 2000 | 0 | 64 | 64 |
| 2001 | 0 | 66 | 66 |
| 2002 | 0 | 75 | 75 |
| 2003 | 0 | 99 | 99 |
| 2004 | 0 | 101 | 101 |
| 2005 | 0 | 91 | 91 |
| 2006 | 0 | 107 | 107 |
| 2007 | 1 | 126 | 127 |
| 2008 | 0 | 123 | 123 |
| 2009 | 1 | 131 | 132 |
| 2010 | 1 | 137 | 138 |
| 2011 | 2 | 214 | 216 |
| 2012 | 2 | 182 | 184 |
| 2013 | 2 | 184 | 186 |
| 2014 | 0 | 217 | 217 |
| 2015 | 0 | 254 | 254 |
| 2016 | 2 | 256 | 258 |
| 2017 | 0 | 280 | 280 |
| 2018 | 0 | 164 | 164 |
| 2019 | 1 | 126 | 127 |
| 2020 | 0 | 101 | 101 |
| 2021 | 0 | 63 | 63 |
| 2022 | 0 | 26 | 26 |
| 2023 | 0 | 26 | 26 |
| 2024 | 0 | 26 | 26 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease-Free Survival" by people in Profiles.
-
Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data. ESMO Open. 2024 Nov; 9(11):103934.
-
Posttreatment surveillance intensity and overall survival in prostate cancer survivors (AFT-30). JNCI Cancer Spectr. 2024 Nov 01; 8(6).
-
Impact of systemic therapy on clinical T1 small-cell neuroendocrine carcinoma of the bladder. ESMO Open. 2024 Nov; 9(11):103964.
-
Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study. Gynecol Oncol. 2024 Dec; 191:143-149.
-
Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer. N Engl J Med. 2024 Oct 03; 391(13):1206-1216.
-
Survival outcomes of adjuvant chemotherapy in patients with stage I?pancreatic cancer stratified by pathologic risk. Surgery. 2024 Nov; 176(5):1466-1474.
-
Comparison of robotic and laparoscopic surgery for sigmoid colon and rectal cancer: a single-center retrospective study on surgical outcomes and long-term survival. J Robot Surg. 2024 Jul 29; 18(1):299.
-
15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1). J Clin Oncol. 2024 Oct; 42(28):3319-3329.
-
A Systematic Review of Clinical Trials Comparing Radiation Therapy Versus Radical Prostatectomy in Prostate Cancer. Clin Genitourin Cancer. 2024 Oct; 22(5):102157.
-
Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010. Eur Urol Oncol. 2024 Dec; 7(6):1175-1178.